According to Stratistics MRC, the Global Multiplex Assays market is estimated at $2.90 billion in 2016 and is expected to reach $5.09 billion by 2023 growing at a CAGR of 8.3% from 2016 to 2023. Growing demand for high throughput and automated systems will offer a significant growth opportunity over the forecast period. Some of the factors such as rising safety & efficiency of therapies, growing advantages of multiplexing over conventional assays and improving validation for biomarkers are contributing the market growth. However, huge capital investments and shortage of skilled labour are negatively affecting the market.
Browse The Report: http://orbisresearch.com/reports/index/multiplex-assays-global-market-outlook-2017-2023
In recent, technological advancements in multiplex assays have the potential to appraise the difficulty of analytes, such as amino acids and proteins, in a better manner. In 2016, Merck launched Milliplex Map Equine-specific multiplex assay that can measure 27 cytokines simultaneously and delivers important information about immune response, inflammation, and general health.
Based on geography, North America commanded the largest market share followed by Europe. Furthermore, Asia Pacific is expected to grow at a fastest rate during the forecast period owing to increasing prevalence of Alzheimer patients, rise in pool of patient population and major growth in R&D activities (pharmaceuticals) across the region.
Some of the key players in this market include Randox Laboratories Ltd., Seegene Inc., Becton, Dickinson and Company, Qiagen N.V., Illumina, Inc., Luminex Corporation, Meso Scale Diagnostics, LLC, Merck KGAA, Abcam PLC, Bio-Rad Laboratories Inc. and Thermo Fisher Scientific Inc.
Technologies Covered:
Multiplex Arrays
Multiplex PCR
Protein Microarray
Other Technologies
Request a Free Sample of The Report: http://orbisresearch.com/contacts/request-sample/2028282
Product and Services Covered:
Multiplex Assay Instruments
Multiplex Assay Accessories
Software and Services
Multiplex Assay Consumables
Assays Types Covered:
Nucleic Acid-Based Multiplex Assays
Protein-Based Multiplex Assays
Other Multiplex Assays
Applications Covered:
Research & Development
Diseases & Disorders
Companion Diagnostics
Other Applications
End Users Covered:
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals
Clinical Laboratories
Other End Users
Regions Covered:
North America
US
Canada
Mexico
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
Japan
China
India
Australia
New Zealand
South Korea
Rest of Asia Pacific
South America
Argentina
Brazil
Chile
Rest of South America
Middle East & Africa
Saudi Arabia
UAE
Qatar
South Africa
Rest of Middle East & Africa
What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com